These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 29329348)

  • 1. Correction: Risk of thromboembolism in cisplatin versus carboplatin-treated patients with lung cancer.
    PLOS Staff
    PLoS One; 2018; 13(1):e0191454. PubMed ID: 29329348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of thromboembolism in cisplatin versus carboplatin-treated patients with lung cancer.
    Kim ES; Baran AM; Mondo EL; Rodgers TD; Nielsen GC; Dougherty DW; Pandya KJ; Rich DQ; van Wijngaarden E
    PLoS One; 2017; 12(12):e0189410. PubMed ID: 29228042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction: Preclinical Assessment of Carboplatin Treatment Efficacy in Lung Cancer by 18F-ICMT-11-Positron Emission Tomography.
    Witney TH; Fortt R; Aboagye EO
    PLoS One; 2020; 15(7):e0235804. PubMed ID: 32645089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction: Modulating lysosomal function through lysosome membrane permeabilization or autophagy suppression restores sensitivity to cisplatin in refractory non-small-cell lung cancer cells.
    Circu M; Cardelli J; Barr MP; O'Byrne K; Mills G; El-Osta H
    PLoS One; 2018; 13(5):e0197016. PubMed ID: 29718985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction: Generation and Characterisation of Cisplatin-Resistant Non-Small Cell Lung Cancer Cell Lines Displaying a Stem-Like Signature.
    Barr MP; Gray SG; Hoffmann AC; Hilger RA; Thomale J; O'Flaherty JD; Fennell DA; Richard D; O'Leary JJ; O'Byrne KJ
    PLoS One; 2020; 15(5):e0233739. PubMed ID: 32437439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction: A Newfound Association between MDC1 Functional Polymorphism and Lung Cancer Risk in Chinese.
    PLOS ONE Staff
    PLoS One; 2015; 10(1):e0117882. PubMed ID: 25635879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction: Coenzyme Q10 plus Multivitamin Treatment Prevents Cisplatin Ototoxicity in Rats.
    Astolfi L; Simoni E; Valente F; Ghiselli S; Hatzopoulos S; Chicca M; Martini A
    PLoS One; 2017; 12(9):e0185525. PubMed ID: 28934353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction: Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis.
    Cohen AT; Hamilton M; Bird A; Mitchell SA; Li X; Horblyuk R; Batson S
    PLoS One; 2016; 11(9):e0163386. PubMed ID: 27631606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction: Immune Responses to the Cancer Testis Antigen XAGE-1b in Non Small Cell Lung Cancer Caucasian Patients.
    Sardaro A; Saito K; Nakayama E; Valmori D
    PLoS One; 2016; 11(7):e0160538. PubMed ID: 27467222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction: Cisplatin-Induced Non-Oliguric Acute Kidney Injury in a Pediatric Experimental Animal Model in Piglets.
    Santiago MJ; Fernández SN; Lázaro A; González R; Urbano J; López J; Solana MJ; Toledo B; Del Castillo J; Tejedor A; López-Herce J
    PLoS One; 2018; 13(11):e0207547. PubMed ID: 30412623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence supporting the superiority of intraperitoneal cisplatin compared to intraperitoneal carboplatin for salvage therapy of small-volume residual ovarian cancer.
    Markman M; Reichman B; Hakes T; Rubin S; Lewis JL; Jones W; Barakat R; Curtin J; Almadrones L; Hoskins W
    Gynecol Oncol; 1993 Jul; 50(1):100-4. PubMed ID: 8349150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction: Classification of Lung Cancer Tumors Based on Structural and Physicochemical Properties of Proteins by Bioinformatics Models.
    Hosseinzadeh F; Ebrahimi M; Goliaei B; Shamabadi N
    PLoS One; 2012; 7(12):. PubMed ID: 29161736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin and carboplatin-based chemotherapy in the first-line treatment of non-small cell lung cancer: Analysis from the European FRAME study.
    Smit E; Moro-Sibilot D; Carpeño Jde C; Lesniewski-Kmak K; Aerts J; Villatoro R; Kraaij K; Nacerddine K; Dyachkova Y; Smith KT; Girvan A; Visseren-Grul C; Schnabel PA
    Lung Cancer; 2016 Feb; 92():35-40. PubMed ID: 26775594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction: Lung and heart-lung transplantation in pulmonary arterial hypertension.
    López-Meseguer M; Quezada CA; Ramon MA; Lázaro M; Dos L; Lara A; López R; Blanco I; Escribano P; Roman A;
    PLoS One; 2018; 13(1):e0192100. PubMed ID: 29377947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction: Cancer Mortality in People Treated with Antidepressants before Cancer Diagnosis: a Population Based Cohort Study.
    Sun Y; Vedsted P; Fenger-Grøn M; Wu CS; Bech BH; Olsen J; Benros ME; Vestergaard M
    PLoS One; 2016; 11(5):e0155453. PubMed ID: 27152664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis.
    Ardizzoni A; Boni L; Tiseo M; Fossella FV; Schiller JH; Paesmans M; Radosavljevic D; Paccagnella A; Zatloukal P; Mazzanti P; Bisset D; Rosell R;
    J Natl Cancer Inst; 2007 Jun; 99(11):847-57. PubMed ID: 17551145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction: evaluating predictive pharmacogenetic signatures of adverse events in colorectal cancer patients treated with fluoropyrimidines.
    Jennings BA; Loke YK; Skinner J; Keane M; Chu GS; Turner R; Epurescu D; Barrett A; Willis G
    PLoS One; 2015; 10(4):e0124893. PubMed ID: 25876069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction: Evaluation of lung toxicity risk with computed tomography ventilation image for thoracic cancer patients.
    Otsuka M; Monzen H; Matsumoto K; Tamura M; Inada M; Kadoya N; Nishimura Y
    PLoS One; 2019; 14(11):e0225965. PubMed ID: 31774868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction: Methylation Markers of Early-Stage Non-Small Cell Lung Cancer.
    Lokk K; Vooder T; Kolde R; Välk K; Võsa U; Roosipuu R; Milani L; Fischer K; Koltsina M; Urgard E; Annilo T; Metspalu A; Tõnisson N
    PLoS One; 2017; 12(1):e0170833. PubMed ID: 28107536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction: Potential therapeutic impact of CD13 expression in non-small cell lung cancer.
    Schmidt LH; Brand C; Stucke-Ring J; Schliemann C; Kessler T; Harrach S; Mohr M; Görlich D; Marra A; Hillejan L; Müller-Tidow C; Lenz G; Wardelmann E; Wiewrodt R; Berdel WE; Schwöppe C; Hartmann W
    PLoS One; 2017; 12(8):e0183201. PubMed ID: 28793330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.